The efficacy and tolerability of Artesunate-Mefloquine fixed-dose combination (ASMQ FDC) was tested in children under 5 years of age with uncomplicated falciparum malaria. The results of a multi-centre clinical trial in Africa, launched in 2008 was presented today at the 63rd annual meeting of the American Society of Tropical Medicine and Hygiene (ASMTH). The results revealed that ASMQ FDC is as safe and efficacious as Artemether-Lumefantrine (AL) FDC - Africa's most widely ...Wednesday 5 November 2014
Treating Malaria in African Children With ASMQ-FDC is Safe
The efficacy and tolerability of Artesunate-Mefloquine fixed-dose combination (ASMQ FDC) was tested in children under 5 years of age with uncomplicated falciparum malaria. The results of a multi-centre clinical trial in Africa, launched in 2008 was presented today at the 63rd annual meeting of the American Society of Tropical Medicine and Hygiene (ASMTH). The results revealed that ASMQ FDC is as safe and efficacious as Artemether-Lumefantrine (AL) FDC - Africa's most widely ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment